UK markets closed

China Health Group Inc. (8225.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
0.132+0.022 (+20.00%)
At close: 02:45PM HKT

China Health Group Inc.

Building 17
Jianwai SOHO Chayoyang District
Beijing 102200
China
86 21 6115 8121
https://www.chgi.net

Sector(s)Healthcare
IndustryDiagnostics & Research
Full-time employees42

Key executives

NameTitlePayExercisedYear born
Dr. Xuemei SongHead of HR Mgmt Dept, Compliance Officer & Executive Director295.96kN/A1968
Mr. Liang LiFinancial DirectorN/AN/AN/A
Dr. Tuo JinJoint Chief Technology Officer and Member of Scientific Advisory BoardN/AN/A1953
Mr. Tsz Ngo YuCompany SecretaryN/AN/A1986
Dr. Yiu Kwong SunAdviser for Medical Affairs and Member of Corporate Advisory BoardN/AN/AN/A
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in HKD.

Description

China Health Group Inc., an investment holding company, provides clinical research services to pharmaceutical and biotechnology companies in the People's Republic of China. The company offers contracted clinical research services; contracted pharmaceutical development services; post launch market research, medical, and medical market services; and other medical services. It also provides hospital management, medical tourism, and specialized hospital services, as well as Venturepharma cloud; and sells drug technologies. The company was formerly known as Venturepharm Laboratories Limited and changed its name to China Health Group Inc. in January 2015. China Health Group Inc. was founded in 1998 and is headquartered in Beijing, China.

Corporate governance

China Health Group Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.